Sarcopenic Obesity: Estimation of Prevalence and Identification of Clinical and Biological Determinants in a Population of Adult Obese Patients (OBESAR)

University Hospital, Clermont-Ferrand

Status

Unknown

Conditions

Obesity

Treatments

Other: collection

Study type

Interventional

Funder types

Other

Identifiers

NCT03394469

CHU-366

2017-A01510-53. (Other Identifier)

Details and patient eligibility

About

This project aims first to determine the prevalence of sarcopenia in a population of obese people of extended age group (18-70 years). In a second step, the factors determining and / or predisposing to sarcopenic obesity will be identified as well as plasmatic and urinary biomarkers specific to this phenotype.

Full description

Collection of clinical and paraclinical data (biological and anthropometric) for evaluation of sarcopenic obesity in obese patients.

Biological collection to identify plasma, serum, genetic, urinary and faecal biomarkers associated with sarcopenic obesity

Enrollment

800 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age: 18-70 years
Sex: men and women
Patient followed in clinical nutrition benefiting from a metabolic assessment for optimization of clinical and paraclinical management
Patient meeting the criteria of obesity defined by BMI> 30 kg / m²
Major patient with free, informed and signed consent
Patient covered by the social security scheme

Exclusion criteria

Patient with cancer or severe chronic disease (renal failure, respiratory failure, liver failure)
Patient with neuromuscular disease
Patient with a total inability to walk
Minor patient
Refusal of the patient to participate in the study
Pregnant or lactating women
Patient deprived of liberty or under guardianship.